Company profile for Microbio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Microbio Co., Ltd., established in May 2000, is a biotechnology company focused on developing high-end medicines and healthcare products. With a strong commitment to innovation, we have built advanced pharmaceutical technology platforms and achieved major breakthroughs in biotech research. Our portfolio includes new drugs like Chemo Young and Herbiron, alongside health products such as Tien Chun Boo and Lee Herb series. Throug...
Microbio Co., Ltd., established in May 2000, is a biotechnology company focused on developing high-end medicines and healthcare products. With a strong commitment to innovation, we have built advanced pharmaceutical technology platforms and achieved major breakthroughs in biotech research. Our portfolio includes new drugs like Chemo Young and Herbiron, alongside health products such as Tien Chun Boo and Lee Herb series. Through our diversified group, including Oneness Biotech and Cotton Field Organic, we drive global biotech innovation while fulfilling our social responsibilities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
14F-1, No. 3-1, Yuanqu St., Nangang Dist., Taipei City 115603
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sns812-an-innovative-sirna-drug-from-oneness-and-microbio-shanghai-selected-for-ats-2025-oral-presentation-demonstrating-world-leading-clinical-outcomes-in-covid-19-treatment-302457583.html

PR NEWSWIRE
16 May 2025

https://www.prnewswire.com/news-releases/microbio-co-ltd-announces-promising-results-of-ms-20-as-an-add-on-therapy-for-ulcerative-colitis-302402585.html

PR NEWSWIRE
17 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty